People should not treat the BA.2 variant separately from Omicron “unless evidence emerged that there might be a meaningful (disease difference between the two,” said Professor Francois Balloux (UCL Genetics Institute).
Read: Mail Online, More: Newsweek, Telegraph (£), Sky News